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What is already known about the topic?
•• The involvement of informal carers is essential for the provision of palliative care, but informal caregiving can have a major 
impact on carers’ outcomes.
•• Studies of informal carer outcomes use a wide range of endpoints.
•• Selecting suitable and appropriate carer outcome measures seems problematic.
Psychometric properties of carer-reported 
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Abstract
Background: Informal carers face many challenges in caring for patients with palliative care needs. Selecting suitable valid and reliable 
outcome measures to determine the impact of caring and carers’ outcomes is a common problem.
Aim: To identify outcome measures used for informal carers looking after patients with palliative care needs, and to evaluate the 
measures’ psychometric properties.
Design: A systematic review was conducted. The studies identified were evaluated by independent reviewers (C.T.J.M., M.B., M.P.). 
Data regarding study characteristics and psychometric properties of the measures were extracted and evaluated. Good psychometric 
properties indicate a high-quality measure.
Data sources: The search was conducted, unrestricted to publication year, in the following electronic databases: Applied Social 
Sciences Index and Abstracts, Cumulative Index to Nursing and Allied Health Literature, The Cochrane Library, EMBASE, PubMed, 
PsycINFO, Social Sciences Citation Index and Sociological Abstracts.
Results: Our systematic search revealed 4505 potential relevant studies, of which 112 studies met the inclusion criteria using 38 
carer measures for informal carers of patients with palliative care needs. Psychometric properties were reported in only 46% (n = 52) 
of the studies, in relation to 24 measures. Where psychometric data were reported, the focus was mainly on internal consistency 
(n = 45, 87%), construct validity (n = 27, 52%) and/or reliability (n = 14, 27%). Of these, 24 measures, only four (17%) had been formally 
validated in informal carers in palliative care.
Conclusion: A broad range of outcome measures have been used for informal carers of patients with palliative care needs. Little 
formal psychometric testing has been undertaken. Furthermore, development and refinement of measures in this field is required.
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What this paper adds?
•• An increasing number of studies are conducted in informal carers looking after patients with palliative care needs.
•• Only four outcome measures have been formally developed and validated within this population, and limited psychometric 
information is available on most measures.
•• While there has been an increasing trend since 2008 in the use of outcome measures for informal carers in palliative care 
research, most measures used in these studies were developed more than 20 years earlier and may not adhere to current 
standards for measure development.
Implications for practice, theory or policy
•• Existing carer outcome measures need to be validated for the palliative care setting and new measures need to be devel-
oped in accordance with current guidelines in order to meet the requirements of the growing number of studies, including 
intervention studies, of informal carers looking after patients with palliative care needs.
•• When using an existing outcome measure, the authors should report their rationale for selecting it and should refer to the 
publications that report the original development of the measure.
•• Interventions for supporting informal carers should be evaluated using outcome measures for which appropriate psycho-
metric properties have been reported before they are implemented as policy.
Introduction
The World Health Organization (WHO)1 defines palliative 
care as an approach that focuses on the quality of life of 
patients and their relatives facing problems associated 
with life-threatening illness, through prevention and relief 
of suffering. Annually, around 20 million people world-
wide need palliative care,2 and an ageing population and 
increases in long-term conditions mean that need is likely 
to continue to rise.3,4
Informal carers make an important contribution in the 
provision of palliative care and are regarded as integral to 
its delivery.5,6 Informal carers are defined as carers who 
are not financially compensated for their services typically 
spouses, children, siblings or friends.7 In 2011, the contri-
bution of approximately six million informal carers in the 
United Kingdom was estimated at the equivalent of 
£119 billion a year.8 About half a million people are caring 
for patients during the end-of-life phase and this number is 
expected to increase to 3.4 million in the coming 30 years.9
Palliative care has become an important component of 
health care, and policy makers are putting more emphasis 
on informal carers.10 Informal caregiving may provide 
emotional benefits and togetherness for carers,11,12 but it 
also involves considerable challenges including adverse 
psychological, physical, social and financial conse-
quences.13,14 Studies indicate that informal caregiving 
affects carers’ wellbeing and their own health resulting in 
isolation, fatigue, sleeping problems, exhaustion, weight 
loss, depression and anxiety.15–19 It is therefore important 
that carer outcomes are assessed in order to be able to 
provide effective support and to reduce negative conse-
quences of caregiving. Carer outcomes refer to a range of 
concepts including quality of life, burden and strain. 
While these terms are not well defined and frequently get 
used interchangeably, it is generally accepted that they 
comprise multiple dimensions such as physical impact, 
mental strain and social functioning. It has been argued 
that quality of life is a broader concept as it assesses a 
wider spectrum of wellbeing, whereas burden and strain 
suggest a more direct measure of duty of care.20
Evidence on effective strategies to reduce the burden 
of caring and improve their quality of life of informal car-
ers is limited.21,22 Although interventions have been devel-
oped that aim to improve outcomes for informal carers, 
their results are difficult to compare as studies focus on a 
wide range of endpoints.23 One systematic review identi-
fied 62 questionnaires used among informal family carers 
in various palliative care settings.24 These questionnaires 
included instruments on carer satisfaction, experience (of 
health services and support), needs bereavement and out-
comes. Previous reviews on interventions for informal 
carers concluded that it was unclear what kind of support 
was beneficial, partly due to the lack of appropriate out-
come measures.21,25
In order to assess the impact of the caring role on carers, 
an appropriate choice of outcome measures is required; 
however, selecting suitable and appropriate measures 
seems a common problem.25–27 This requires reliable and 
valid measures with robust psychometric properties, which 
are appropriate for a palliative care context, as this forms 
the foundation for evaluating caregiver interventions.
This systematic review aimed to identify and evaluate 
outcome measures that have been used for informal carers 
in palliative care studies. The measures used in palliative 
care are described and their psychometric properties (e.g. 
reliability, validity, feasibility and precision), when avail-
able, are evaluated.
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Methods
Search strategy
We conducted a systematic review of carer outcome meas-
ures used in palliative care, according to Cochrane guide-
lines.28 The databases, Applied Social Sciences Index and 
Abstracts (ASSIA), the Cochrane Library, Cumulative 
Index to Nursing and Allied Health Literature (CINAHL), 
EMBASE, PubMed, PsycINFO, Social Sciences Citation 
Index and Sociological Abstracts, were searched using four 
main terms: palliative care, informal carers, outcomes and 
measures. The search strategy is presented in Table 1 and 
further detailed search histories are available from the cor-
responding author on request. All identified citations were 
imported into the bibliographic database of EndNote, ver-
sion X5 (Thomas Reuters, New York, NY). Reference lists 
of the retrieved articles were screened for additional studies.
Study selection
All types of multidimensional measures (generic, carer-
specific for any condition and carer-specific for patients 
with a specific condition) were eligible for inclusion. The 
study focused on multidimensional measures as we were 
interested in measures that assess the overall impact of car-
ing in palliative care rather than measures that assess one 
specific dimension of outcome or impact. A study was 
included if all of the following were fulfilled: (1) the study 
used a self-reported multidimensional measure that 
assessed caregiver outcomes (i.e. burden, strain or quality 
of life), (2) measures were directed at unpaid informal car-
ers (e.g. spouse, relatives, siblings, friends or neighbours), 
(3) the patients they supported were diagnosed with an 
advanced progressive illness or were receiving palliative 
care (end-of-life care, terminal care or hospice care), (4) 
both carers and patients were ⩾18 years old and (5) the 
study was reported in English.
A study was excluded if any of the following were ful-
filled: (1) only unidimensional measures were used; (2) 
only subscales or individual items and not the full measure 
were included; (3) only clinician-assessed measures or 
patient-reported measures were used; (4) all measures 
completed by carers were on behalf of the patient or (5) it 
was a qualitative study, comment, editorial, protocol, con-
ference article or grey literature. There were no restrictions 
regarding publication date and research methods.
Table 1. Search strategy employed in systematic review of studies on psychometric properties of carer-reported outcome 
measures in palliative care.
Main search terms Search terms (PubMed database)
Palliative care palliative care[Mesh Terms] OR hospice care[Mesh Terms] OR hospices[Mesh Terms] OR 
palliative*[title/abstract] OR terminal care[title/abstract] OR terminal ill[title/abstract] OR hospice*[title/
abstract] OR end-of-life care[title/abstract] OR end-of-life care[title/abstract] OR end-stage[title/abstract]
AND
Caregivers caregivers[Mesh Terms] OR family[Mesh Terms] OR spouses[Mesh Terms] OR volunteers[Mesh 
Terms] OR (family[title/abstract] AND (caregiver*[title/abstract] OR care giver*[title/abstract] OR 
caregiving[title/abstract] OR care giving[title/abstract] OR carer*[title/abstract])) OR (informal[title/
abstract] AND (caregiver*[title/abstract] OR care giver*[title/abstract] OR caregiving[title/abstract] OR 
care giving[title/abstract] OR carer*[title/abstract])) OR (volunteer*[title/abstract] AND (caregiver*[title/
abstract] OR care giver*[title/abstract] OR caregiving[title/abstract] OR care giving[title/abstract] OR 
carer*[title/abstract])) OR (unpaid[title/abstract] AND (caregiver*[title/abstract] OR care giver*[title/
abstract] OR caregiving[title/abstract] OR care giving[title/abstract] OR carer*[title/abstract])) OR 
spouse*[title/abstract] OR husband*[title/abstract] OR wife*[title/abstract] OR family[title/abstract] OR 
volunteer*[title/abstract] OR unpaid[title/abstract] OR informal[title/abstract]
AND
Outcomes quality of life[Mesh Terms] OR quality of life[title/abstract] OR QOL[title/abstract] OR anxiety[title/
abstract] OR benefit*[title/abstract] OR burden[title/abstract] OR competence*[title/abstract] OR 
coping[title/abstract] OR confidence[title/abstract] OR impact[title/abstract] OR need*[title/abstract] 
OR preparedness[title/abstract] OR satisfaction[title/abstract] OR self-assurance[title/abstract] OR 
strain*[title/abstract] OR stress[title/abstract] OR support[title/abstract] OR wellbeing[title/abstract]
AND
Questionnaires questionnaires[Mesh Terms] OR self-report[Mesh Terms] OR outcome assessment (health care)
[Mesh Terms] OR psychometrics[Mesh Terms] OR assessment*[title/abstract] OR instrument*[title/
abstract] OR measure*[title/abstract] OR outcome*[title/abstract] OR psychometric*[title/abstract] OR 
psychometry[title/abstract] OR tool*[title/abstract] OR questionnaire*[title/abstract] OR reliability[title/
abstract] OR reliable [title/abstract] OR reproducibility[title/abstract] OR scale*[title/abstract] OR self-
report[title/abstract] OR survey [title/abstract] OR validated[title/abstract] OR validation[title/abstract] 
OR validity[title/abstract]
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Data extraction and analysis
After retrieving all records, the duplicates were removed. 
All studies were initially screened on the basis of title and 
abstract, and then on the basis of full-text. Three authors 
(C.T.J.M., M.B. and M.P.) independently assessed the eligi-
bility of studies: C.T.J.M. assessed all articles, M.B. and 
M.P. each assessed half of the articles. Any uncertainties 
were discussed with the other two authors (A.A. and B.W.) 
and resolved by consensus. C.T.J.M. extracted the data on 
study characteristics (publication year, country, sample size, 
research setting, type of disease, intended outcome measure 
and information on measure) and psychometric charac- 
teristics. The following information on psychometrics was 
collected: content validity, internal consistency, construct 
validity, reproducibility (agreement and reliability), res- 
ponsiveness, floor or ceiling effects, acceptability and 
feasibility. As guidance, we used the definitions given by 
Terwee et al.29 and Fitzpatrick et al.30 Additionally, when an 
included study did not report any psychometric information 
but referred to other articles regarding a measure or its 
psychometric values, we assessed these additional articles 
in order to evaluate the evidence they provided.
Results
Our electronic search, performed on 4 September 2014, 
identified 8569 studies. Figure 1 provides an overview of 
the number of studies identified at each stage of the search. 
After duplicates were removed, 4505 studies were screened 
on the basis of titles and abstracts, and 231 studies were 
screened on the basis of full text. This identified 112 stud-
ies using 38 different measures for informal carers in pal-
liative care.
Study and measure characteristics
A total of 112 studies (18 randomized controlled trials 
(RCTs), 78 observational studies and 16 methodological 
studies) were included. The methodological studies 
included translation, development and validation studies 
about an outcome measure for informal carers in palliative 
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Records excluded (n = 4,274)
• Not about palliave care 
• No types of carer reported outcome 
measures 
• No informal, unpaid caregiver 
• Open interviews or open-ended quesons 
• Irrelevant or unsuitable outcomes
• Grey literature
• Conference papers 
Full-text arcles excluded (n = 107)
• No muldimensional carer reported 
outcome measure (n = 30)
• No informal, unpaid caregiver (n = 14)
• Not about palliave care (n = 20)
• Irrelevant or unsuitable outcomes (n = 13)
• Grey literature, excluded publicaon 
types, non-English (n = 30)
Studies included in systemac review 
(n = 112). Number of measures included in 
the review (n = 38)
Full-text arcles included aer snowballing 
reference list of 112 included full-text arcles 
(n = 0)
Full-text arcles assessed for eligibility 
(n = 219)
Records idenfied through database 
search (n = 8,569)
• Pubmed (n = 2,345) 
• Embase (n = 2,399)
• PsycINFO (n = 734)
• The Cochrane library (n = 241)
• CINAHL (n = 1,077)
• Applied Social Sciences Index and 
Abstracts (n = 27)
• Social sciences citaon index 
(n = 1,672)
• Sociological abstracts (n = 74)
Records aer duplicates removed 
(n = 4,505)
Records screened on basis of tle/abstract 
(n = 4,505)
Figure 1. PRISMA flow diagram of study selection.
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care. The patient population mainly consisted of cancer 
patients (n = 67, 60%) or a mixture of conditions (n = 29, 
26%). Of the studies, 37% were conducted in the United 
States. Most studies included a mix of spouses, children, 
parents or friends (n = 99, 88%) and a small number of stud-
ies included only spouse carers (n = 4, 3%).
Most studies used only one outcome measure that fit 
our selection criteria (n = 91, 81%) and 19% of the studies 
administered two outcome measures to carers. Studies 
mainly used carer-specific measures only (n = 69, 62%), a 
quarter used a generic measure (n = 29, 26%), and 14 stud-
ies used both types (i.e. generic and carer-specific). In 
total, 38 measures were identified, including 25 carer-spe-
cific measures and 13 generic measures. The main study 
characteristics are presented in Table 2 and in detail in 
Supplement 1.
The most frequently used generic measure was the 
SF-36 (n = 16, 14%). The most frequently used carer-spe-
cific measures were the Caregiver Reaction Assessment 
(n = 21, 19%), Caregiver Quality of Life Index–Cancer 
(n = 14, 13%) and the Zarit Burden Inventory (n = 10, 9%). 
The primary focus of studies using a carer-specific meas-
ure was burden (n = 14, 13%), followed by quality of life 
(n = 8, 7%) and strain (n = 3, 2.6%). An overview of the 
identified measures and their frequency of use are pre-
sented in Table 3.
Psychometrics of measures
More than half of the 112 (n = 60, 54%) studies reported no 
information on psychometric properties. The 52 (46%) 
studies that did included 33 observational studies, 15 meth-
odological studies and 4 RCTs. Psychometric data were 
available for only 23 of the 38 measures including 7 generic 
measures (i.e. McGill Quality of Life Questionnaire,142 
World Health Organization Quality of Life,143 Quality of 
Life Scale,144 Quality of Life Index,94 SF-36,145 SF-12145 
and Swedish Health-Related Quality of life146) and 17 
carer-specific measures. These measures consisted of 4–64 
items, with a median of 16 items. Table 4 presents an over-
view of the 24 measures with the available psychometric 
information. This consisted mainly of information on the 
Cronbach’s alpha (n = 45, 40%), construct validity (n = 27, 
24%), reliability (n = 14, 12%), content validity (n = 8, 7%), 
responsiveness (n = 8, 7%) and acceptability and feasibility 
(n = 8, 7%).
Of the 24 measures, four were originally developed in a 
palliative care context, that is, the Quality of Life in Life-
Threatening Illness–Family Carer Version (QOLLTI-F),34 
the Family Appraisal of Caregiving Questionnaire for 
Palliative Care (FACQ-PC),35 the Caregiver Burden Scale 
in end-of-life-care (CBS-EOLC)36 and the Caregiver 
Quality of Life Index (CQOLI).94 The content validity 
(which examines the extent to which the concepts of inter-
est are represented by the items201), internal consistency 
(which measures the extent to which items in a scale are 
inter correlated29) and construct validity (the extent to 
which scores relate to other similar measured concepts29) 
were adequate in all four measures. Interpretability (the 
degree to which one can assign qualitative meaning to 
quantitative scores) was not reported in all four studies. 
The reliability (which concerns the degree to which 
repeated measurements in stable persons provide similar 
answers29) was positive in two measures34,94 and negative 
for FACQ-PC.35 Floor and ceiling effects (considered to be 
present if more than 15% of respondents achieved the low-
est or highest possible score, indicating that it is likely that 
extreme items are missing in the lower or upper ends of the 
scale202) was negative for QOLLTI-F34 and not reported 
for the other three measures.35,36,94
For studies (n = 60) that did not report psychometric 
properties but referred to previous publications about the 
measure, C.T.J.M. additionally extracted psychometric 
information from the referenced articles (see Supplement 
2). An additional 139 references were assessed for study 
type, study population and psychometric properties. 
Although this provided information on how the measures 
were originally developed, it did not result in additional 
psychometric information for the measures in the context 
of carers in a palliative care setting.
Discussion
The aim of this systematic review was to identify and eval-
uate the psychometric properties of self-reported measures 
used in informal carers in palliative care studies. A total of 
112 studies were found, which used 38 different outcome 
measures for informal carers. The most commonly used 
generic measure was the SF-36 (n = 27) and the most com-
monly used carer-specific measure was the Caregiver 
Reaction Assessment (n = 21). Psychometric information 
was available for only 24 carer outcome measures (52 
studies). We identified only four measures that were for-
mally tested in a palliative care context.
Measures were mainly used in descriptive studies 
(n = 78) and the overall study sample sizes tended to be 
quite small. This could be due to methodological and 
structural challenges in palliative care research.203 For 
example, uncertainties in patients’ prognosis, heterogene-
ity of the palliative care population, relatively small pallia-
tive care centres, ethical concerns or attrition of patients 
during the study could inhibit research in palliative care.
We noted an increasing trend in the use of measures in 
informal carers in palliative care. The majority of the 
included studies were published relatively recently, with 
more than 70% published since 2008. However, the major-
ity of measures were developed much longer ago, includ-
ing the most frequently used such as the Caregiver Reaction 
Assessment165 or the Zarit Burden Interview.155 It is there-
fore unclear whether measures adhere to the current 
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development guidelines, such as those set by the Food and 
Drug Administration for patient-reported outcome meas-
ures.204 Evaluating publications on the development of 
these outcome measures was beyond the scope of our 
review, and the information would have been of limited 
value as the measures were mainly developed in other 
carer populations.
Due to the wide range of identified carer outcome 
measures and the variety of versions of the measures (e.g. 
Zarit Burden Interview; Table 3), it is difficult to draw 
overall conclusions about psychometric properties. The 
most commonly reported psychometric information was 
Cronbach’s alpha (n = 45, 40%), which is a psychometric 
property that is commonly used, relatively easy to calcu-
late and easy to interpret. In all, 60 did not report any 
psychometric information. It was not expected that all 
studies would contain psychometric information, as the 
lack of psychometrics was not an exclusion criterion. For 
studies that did not report psychometric properties but 
referred to previous publications about the measure, we 
screened an additional 139 references for information on 
psychometrics. However, these resulted in limited extra 
psychometric data, and none of the studies met the inclu-
sion criteria of this systematic review.
Although psychometric information was generally lim-
ited, it was even more limited in relation to some psycho-
metric properties such as responsiveness. Responsiveness 
(or sensitivity to change) is particularly important to high-
light as carer-reported outcome measures may be used to 
assess the effectiveness of interventions. Interventions to 
support carers in palliative care settings are likely to be 
complex and require measures that are able to detect 
change following the intervention.
We identified only four carer-specific measures that 
were formally developed and tested in this population: 
QOLLTI-F,34 FACQ-PC,35 CBS-EOLC36 and CQLI.94 
These four measures were used less frequently than either 
the Caregiver Reaction Assessment or the Zarit Burden 
Interview that have not been validated in this population.
Regarding the generic measures, none have been for-
mally validated in this carer population but we found psy-
chometric information on seven94,142–146 measures. As 
Table 3. Identified outcome measures and frequency of use in the included studies.
Measures Number 
of studies
References
Generic measures SF-36 16 33,49,64,68,73,76,77,89,90,99,102,103,119,123,128,139
SF-12 3 63,65,136
SF-8* 3 69,97,121
EORTC QLQ-C30* 3 37,72,118
EQ-5D* 3 40,110,137
QOLS 3 67,72,108
Other (i.e. MS*, MQOL, SWED-QOL, OQOLI*, QOLI, 
WHOQOL and WHOQOL-BREF*)
9 42,93,101,107–109,127,128,130
Carer-specific measures Burden CRA 21 41,47,62,74,75,82,83,99,106,111–116,118,122–124,133,138
ZBI (including 4 item, 6 item, 8 item, 12 item, 
22 item 29 item version)
10 50,53,58,66,77,80,81,91,102,126
CBS 4 33,49,70,135
Other (i.e. BASC*, BCOS, BSFC, CBS-EOLC, 
CBI, CIS, FACS*, HP*, MBCBS, RCAS* and 
BIC)
15 17,31,32,36,38,41,52,54,55,65,71,79,95,105,135
Quality of life CQOLI–Cancer 14 44,46,56,57,59,78,92,96,114,117,125,131,139,140
CQOLI–Revised 5 60,61,120,136,141
QOLLTI-F 4 34,39,43,71
Other (i.e. AQOL-EOL*, CH-QOL-F*, FACT, 
HQOLI* and QOL–Family*)
8 48,51,70,86,94,98,132,134
Strain CSI 7 32,84,87,96,100,129,140
FACQ-PC 4 35,45,85,88
FSQ* 1 104
SF: short form; EORTC QLQ-C30: European Organization for Research and Treatment of Cancer quality-of-life–30-item questionnaire; EQ-5D: EuroQol–5 dimensions; 
QOLS: Quality of Life Scale; MS: Montgomery Scale; MQOL: McGill Quality of Life Questionnaire; SWED-QOL: Swedish Health-Related QOL Survey; OQOLI: Overall 
Quality of Life Index; QOLI: Quality of Life Index; WHOQOL: World Health Organization Quality of Life; WHOQOL-BREF: World Health Organization Quality of Life–
brief form; CRA: Caregiver Reaction Assessment; ZBI: Zarit Burden Inventory; CBS: Caregiver Burden Scale; BASC: brief assessment scale for caregivers; BCOS: Bakas 
Caregiving Outcomes Scale; BSFC: Burden Scale for Family Caregivers; CBS-EOLC: Caregiver’s Burden Scale in end-of-life care; CBI: Caregiver Burden Inventory; CIS: 
Caregiver Impact Scale; FACS: Feelings about Caregiving Scale; HP: Hausliche Pflegeskala; MBCBS: Montgomery Borgatta Caregiver Burden Scale; RCAS: Revised Caregiv-
ing Appraisal Scale; BIC: burden index of caregivers; CQOLI: Caregiver Quality of Life Index; QOLLTI-F: Quality of Life in Life-Threatening Illness–Family Carer Version; 
AQOL-EOL: Assessment Quality of life–End of life–Spouses; CH-QOL-F: City of Hope–QOL Scale–Family Version; FACT: Functional Assessment of Cancer Therapy; 
HQOLI: Hospice Quality of Life Index; QOL: quality of life; CSI: Caregiver Strain index; FACQ-PC: Family Appraisal of Caregiving Questionnaire for Palliative Care; FSQ: 
Family Strain Questionnaire.
*No information reported and available on psychometric properties.
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these have been widely validated in a large number of dif-
ferent populations, it seems reasonable to assume that they 
are applicable for carers in a palliative context as well.
It is interesting that limited psychometric information 
was reported for the most widely used carer-specific meas-
ure, the Caregiver Reaction Assessment.165 This suggests 
that psychometric properties of the measures may not be 
the key factor in researchers’ choice of outcome measures. 
It would be worthwhile exploring in further studies what 
considerations researchers take into account when select-
ing their measures and why some carer-specific measures 
are used more frequently than others, particularly those 
developed specifically for carers in a palliative context.
Choosing the right measure for a particular study can 
be challenging because there may be a number of relevant 
measures from which to choose.205 A systematic review 
would be appropriate valuable method to identify the 
most suitable measure, but it may not always be feasible 
to conduct a systematic review. Alternatively, as our sys-
tematic review highlights, no measure may seem entirely 
appropriate due to a lack of psychometric information. 
Additionally, measures may include items irrelevant to 
the study population, but developing new measures is 
costly and time consuming. Measure listings such as the 
Mapi research trust206 and published systematic reviews 
can assist in selecting an appropriate measure.205 Studies 
in this review did not always reference the measures used 
or when a reference was provided, it was frequently not 
the reference of the development of the measure. We 
encourage authors to reference the original development 
paper(s) of the measure(s) used and to justify their choice 
of instrument.
The findings of this systematic review are in line with 
previously published reviews. Hudson et al.24 identified 62 
tools covering a range of topics including satisfaction, 
experience, bereavement, needs, preparedness, family 
functioning and outcomes. Hudson et al.24 identified a 
larger number of tools than we did as they included instru-
ments, which we specifically excluded. The review con-
cluded that appropriate tools were lacking but the authors 
only gave a broad critical appraisal across substantially 
different types of instruments. In 2009, Whalen and 
Buchholz207 identified 74 caregiver burden screening tools 
for children or adults providing informal care, not specific 
to a palliative care context. Whalen and Buchholz207 
reported that burden measures might seem appropriate for 
informal carers but many are lacking psychometric infor-
mation. Deeken et al.208 searched MEDLINE and PubMed 
from 1966 to 2002 and identified 28 tools on burden 
(n = 17), needs (n = 8) and quality of life (n = 3). Neither 
Whalen and Buchholz nor the Deeken et al. reviews 
focused on palliative care. In contrast, our systematic 
review was conducted in a broader range of databases, spe-
cifically focused on self-reported multidimensional carer 
outcome measures in a palliative care context.
A strength of this systematic review is the comprehen-
sive search of eight databases using four main search terms 
and no date restrictions, which meant we could collate and 
examine the variety of outcome measures that have been 
used with informal carers in a palliative care context. This 
review shows that although there is an increasing number 
of studies of informal carers in palliative care, most of the 
outcome measures used have not been formally validated 
within this carer population.
Another strength of the review is the care that was taken 
with regard to the inclusion criterion of palliative care. 
Palliative care is a complex process and involves a broad 
spectrum of health care services and treatments. Not all 
palliative care studies are labelled as such but refer to ‘hos-
pice care’ or ‘end-of-life care’. These search terms were 
included but provided some challenges. For example, end-
stage renal failure is for some patients a chronic disease 
but when dialysis or treatment is no longer effective, 
patients need a palliative approach. Two palliative care 
experts (A.A. and B.W.) independently assessed each 
study where there was uncertainty to determine whether or 
not it was in a palliative care population.
A limitation of the review is the exclusion of the grey 
literature and literature in languages other than English. It 
is likely that this meant we missed measures published 
outside the standard academic field or validation studies of 
translated measures, which might have provided further 
psychometric information.
A second limitation is rooted in the limitations of litera-
ture itself. Limited psychometric information was availa-
ble, as more than half of the studies (n = 60) did not report 
any psychometric data. We included all studies that used 
multidimensional outcome measures in informal carers in 
palliative care, rather than only development or validation 
studies, as this corresponded to our study aims. We did not 
intend to include only development or validation studies, 
but this may be more appropriate for assessing psychomet-
rics. However, if our inclusion criteria had been limited to 
development or validation studies alone, only four stud-
ies34–36,94 would have been identified. Trends regarding the 
increasing number of publications on carer outcomes in 
palliative care would have been missed. As most of the 
studies did not include psychometric information, we 
could not critically assess the quality of most of the 
measures.
Conclusion
Support for patients receiving care is likely to continue to 
be devolved to informal carers. The WHO has called for 
health care provision to be extended to families, ensuring 
their needs, coping and outcomes are addressed alongside 
those of patients receiving health care services at the end 
of life.209 As more interventions are developed to support 
carers, carers’ outcomes will increasingly be assessed in 
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palliative care context. Although a wide range of measures 
have already been used in this context, very limited formal 
psychometric testing has been undertaken. The frequently 
used measures contain limited psychometric information, 
while the outcome measures developed or validated in this 
context are not frequently used in research. Hence, further 
development and refinement of measures for informal car-
ers in palliative care is required in order to be able to suf-
ficiently support informal carers.
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